BACKGROUND AND PURPOSE: Choline and creatine are commonly used as denominators for other metabolites in ischemic stroke spectroscopy, assuming that they do not change. We investigated their concentration variation over time after stroke. METHODS: Choline and creatine concentrations were measured by proton MR spectroscopic imaging in 51 patients at 5 times up to 3 months after stroke. RESULTS: Choline and creatine levels changed significantly in the ischemic region. Choline was significantly reduced during the first 2 weeks after stroke onset (P=0.034). Creatine was significantly reduced during the whole period of the study (P=0.011). CONCLUSIONS: Choline and creatine concentrations are not reliable denominators for metabolite ratios in acute stroke because their levels vary significantly in ischemic brain regions.
BACKGROUND AND PURPOSE:Choline and creatine are commonly used as denominators for other metabolites in ischemic stroke spectroscopy, assuming that they do not change. We investigated their concentration variation over time after stroke. METHODS:Choline and creatine concentrations were measured by proton MR spectroscopic imaging in 51 patients at 5 times up to 3 months after stroke. RESULTS:Choline and creatine levels changed significantly in the ischemic region. Choline was significantly reduced during the first 2 weeks after stroke onset (P=0.034). Creatine was significantly reduced during the whole period of the study (P=0.011). CONCLUSIONS:Choline and creatine concentrations are not reliable denominators for metabolite ratios in acute stroke because their levels vary significantly in ischemic brain regions.
Authors: Jennifer K Ferris; Sue Peters; Katlyn E Brown; Katherine Tourigny; Lara A Boyd Journal: J Cereb Blood Flow Metab Date: 2017-04-12 Impact factor: 6.200
Authors: Adam M Sonabend; R Morgan Stuart; Jonathan Yun; Ted Yanagihara; Hamed Mohajed; Steven Dashnaw; Samuel S Bruce; Truman Brown; Alex Romanov; Manu Sebastian; Fernando Arias-Mendoza; Emilia Bagiella; Peter Canoll; Jeffrey N Bruce Journal: Neuro Oncol Date: 2011-07-12 Impact factor: 12.300
Authors: Ronald A Yeo; Charles Gasparovic; Flannery Merideth; David Ruhl; David Doezema; Andrew R Mayer Journal: J Neurotrauma Date: 2011-01 Impact factor: 5.269
Authors: Brian Johnson; Michael Gay; Kai Zhang; Thomas Neuberger; Silvina G Horovitz; Mark Hallett; Wayne Sebastianelli; Semyon Slobounov Journal: J Neurotrauma Date: 2012-08-17 Impact factor: 5.269
Authors: Charles Gasparovic; Ronald Yeo; Maggie Mannell; Josef Ling; Robert Elgie; John Phillips; David Doezema; Andrew R Mayer Journal: J Neurotrauma Date: 2009-10 Impact factor: 5.269
Authors: H Saito; K Ogasawara; H Nishimoto; Y Yoshioka; T Murakami; S Fujiwara; M Sasaki; M Kobayashi; K Yoshida; Y Kubo; T Beppu; A Ogawa Journal: AJNR Am J Neuroradiol Date: 2012-11-01 Impact factor: 3.825